Total Funding
86
55
Total FundingVenture - Series Unknown raised
Growth Score 86 in past quarter
-3 pts
Heat Score 55 in past quarter
-4 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
Recent Milestones
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
See more interactive data and historical milestones on desktop for the best experience
58825
Emerging Therapy Solutions is an insurance company that specializes in full management of gene and cell therapy for payers.
- David McLean: Co-Founder and Chief Executive Officer
- Ravi Nalliah: Non Executive Director
About the Company
Emerging Therapy Solutions is an insurance company that specializes in the full management of gene and cell therapy for payers. It focuses on the development of proprietary targeting and segmentation algorithms to break down rare conditions.
The company was founded in 2018 and headquartered in Minneapolis, Minnesota.
